Bonus BioGroup Ltd.

ILA 15.80As of Sun 8 Nov 2026, 12:00 UTC
TASE:BONSHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR (12.91%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.81
PE TTM —
TSR TTM (26.17%)
Mkt cap ILS 184.6M
ROIC (378.47%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 19
17.54%
(2.48%)
Hold 8|3|2|7|11
4Q25
1Q26
2Q26
3Q26
Earnings per shareILS
0.24
0.25
0.27
0.26
23.10%
20.52%
19.86%
11.60%
RevenueILS M
9.245
9.291
9.584
9.405
5.72%
6.89%
7.71%
3.37%
Peers (US$57.67M)
Cap (US$)
PE
124.7M
—
26.82M
—
24.41M
—
57.62M
—
Capital
TTM
5Y
10Y
Leveragex
5.201
1.055
0.926
EBIT/Intx
10.71
0.178
0.148
Own earn%
47.92
(169.96)
(147.85)
Sh yield%
40.97
35.82
33.07
Owners
Insiders/Inst%
5.76
89.71
Short interest%
1.97
SBC / revenue%
4.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
3–12
$1 testx
—
Incr. ROIC%
2